The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | G | Genito urinary system and sex hormones | |
| 2 | G03 | Sex hormones and modulators of the genital system | |
| 3 | G03B | Androgens | |
| 4 | G03BA | 3-oxoandrosten (4) derivatives | |
| 5 | G03BA03 | Testosterone |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 0.12 g |
| PAREN - Parenteral | 18 mg |
| RECTAL - Rectal | 0.12 g |
| SL - Sublingual | 60 mg |
| T-DERMAL - Transdermal | 3 mg |
| T-DERMAL - Transdermal (gel) | 50 mg |
| Active Ingredient | Description | |
|---|---|---|
| Testosterone |
Testosterone, secreted by the testes and its major metabolite dihydrotestosterone (DHT), is responsible for the development of the external and internal genital organs and for maintaining the secondary sexual characteristics (stimulating hair growth, deepening of the voice, development of the libido); for a general effect on protein anabolism; for development of skeletal muscle and body fat distribution; for a reduction in urinary nitrogen, sodium, potassium, chloride, phosphate and water excretion. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ANDRODERM Transdermal system | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| ANDROGEL 1% Gel | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| DEPO-TESTOSTERONE Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| NEBIDO Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RESTANDOL TESTOCAPS Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| SUSTANON Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| TESTAVAN Transdermal gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| TESTIM Transdermal Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| TESTOGEL Gel | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
